Clinical Trials Browser

Observational × Sarcoma × Doxorubicin × Clear all

NCT04055753 2026-05-22

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active not recruiting

Sarcoma